Following encouraging trial results, retatrutide, a new peptide treatment for managing adult-onset metabolic disorder, has received regulatory approval from UK’s Medicines and Healthcare Agency ( https://nikolasovkf919525.mybuzzblog.com/21110860/retatrutide-compound-peptide-british-approval-and-launch